Adagio Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Adagio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adagio Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Adagio Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8k | 1.6k | 1.10 |
| 2025-03-31 | $23k | 38k | 0.61 |
| 2024-12-31 | $114k | 257k | 0.44 |
| 2024-09-30 | $35k | 35k | 1.02 |
| 2024-06-30 | $37k | 34k | 1.10 |
| 2024-03-31 | $195k | 44k | 4.44 |
| 2023-12-31 | $52k | 13k | 3.94 |
| 2023-09-30 | $35k | 21k | 1.70 |
| 2023-06-30 | $3.6k | 3.5k | 1.05 |
| 2023-03-31 | $343k | 286k | 1.20 |
| 2022-12-31 | $488k | 325k | 1.50 |
| 2022-06-30 | $0 | 353k | 0.00 |
| 2022-03-31 | $1.7M | 366k | 4.56 |
| 2021-12-31 | $95k | 13k | 7.24 |